Top Markets
#1 Islamic Coin Islamic Coin +151.46%
#2 DOVU DOVU +50.34%
#3 Velvet Velvet +40.04%
#4 Black Phoenix Black Phoenix +35.02%
#5 Fake World Assets Fake World Assets +19.47%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.10%
#7 Akedo Akedo +17.40%
#8 DoubleZero DoubleZero +16.63%
#9 HOME HOME +14.34%
#10 Cross Cross +10.59%
Coin of the day
Islamic Coin Islamic Coin
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Arecor Therapeutics plc Arecor Therapeutics plc

Arecor Therapeutics plc

AREC
Clasificación en acciones #39891
Arecor Therapeutics PLC is a biopharmaceutical enterprise dedicated to creating... Arecor Therapeutics PLC is a biopharmaceutical enterprise dedicated to creating therapies for diabetes and various other medical conditions. The company utilizes its exclusive Arestat formulation technology platform to both cultivate its own range of specialized products (for diabetes and other ailments) and collaborate with pharmaceutical and biotechnology partners to refine and enhance existing therapeutic formulations. Its pipeline includes AT247, an exceptionally fast-acting insulin aimed at individuals with Type I and Type II diabetes, and AT278, a highly concentrated rapid-acting insulin formulation engineered to hasten insulin absorption following injection. Established in 2007, the company's main office is situated in Little Chesterford, United Kingdom.
Precio por acción
$0.80961743
Última sincronización: 2026-08-13
Capitalización bursátil
$305.68K
Cambio (1 día)
0.00%
Cambio (1 año)
-5.76%
País
GB
Comercio Arecor Therapeutics plc (AREC)

Categoría

Healthcare
Ratio P/B de Arecor Therapeutics plc (AREC)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Arecor Therapeutics plc, el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de Arecor Therapeutics plc desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.2613 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.3483 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.634 -
BE